Skip to main content

D Sullivan

First name:
D
Last name:
Sullivan
Koren, M. J., Giugliano, R. P., Raal, F. J., Sullivan, D., Bolognese, M., Langslet, G., et al. (2014). Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. Circulation, 129(2), 234-43. https://doi.org/10.1161/CIRCULATIONAHA.113.007012 (Original work published 2014)
Gray, H. J., Bell-McGuinn, K., Fleming, G. F., Cristea, M., Xiong, H., Sullivan, D., et al. (2018). Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.12.029 (Original work published 2018)
Mao, C., Howard, T. D., Sullivan, D., Fu, Z., Yu, G., Parker, S. J., et al. Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis. Journal Of Proteomics And Genomics Research, 2(1), 1-12. https://doi.org/10.14302/issn.2326-0793.jpgr-17-1447 (Original work published 2017)
Reilly, E. E., Bohrer, B., Sullivan, D., Essayli, J. H., Farrell, N. R., Brown, T. A., et al. (2021). Registered report: Initial development and validation of the eating disorders safety behavior scale. The International Journal Of Eating Disorders, 54(4), 660-667. https://doi.org/10.1002/eat.23479